BACKGROUND: Sporadic cases of CA-MRSA in persons without risk-factors for MRSA carriage are increasing. CASE PRESENTATION: We report a MRSA cluster among family members of a pig-farmer, his co-workers and his pigs. Initially a young mother was seen with mastitis due to MRSA. Six months later her baby daughter was admitted to the hospital with pneumococcal otitis. After staying five days in hospital, the baby was found to be MRSA positive. At that point it was decided to look for a possible source, such as other family members and house-hold animals, including pigs on the farm, since those were reported as a possible source of MRSA earlier. Swabs were taken from the throat and nares of family members and co-workers. A veterinarian obtained swabs from the nares, throat and perineum of 10 pigs. Swabs were cultured following a national protocol to detect MRSA that included the use of an enrichment broth. Animal and human strains were characterized by PFGE, spa-typing, MLST analysis, SSCmec, AGR typing, and the detection for PVL, LukM, and TSST toxin genes. Three family members, three co-workers, and 8 of the 10 pigs were MRSA positive. With the exception of the initial case (the mother) all persons were solely colonized, with no signs of clinical infections. After digestion with SmaI, none of the strains showed any bands using PFGE. All isolates belonged to spa type t108 and ST398. CONCLUSION: 1. This report clearly shows clonal spread and transmission between humans and pigs in the Netherlands. 2. MLST sequence type 398 might be of international importance as pig-MRSA, since this type was shown earlier to be present in epidemiologically unrelated French pigs and pig-farmers. 3. Research is needed to evaluate whether this is a local problem or a new source of MRSA, that puts the until now successful Search and Destroy policy of the Netherlands at risk.
BACKGROUND: Sporadic cases of CA-MRSA in persons without risk-factors for MRSA carriage are increasing. CASE PRESENTATION: We report a MRSA cluster among family members of a pig-farmer, his co-workers and his pigs. Initially a young mother was seen with mastitis due to MRSA. Six months later her baby daughter was admitted to the hospital with pneumococcal otitis. After staying five days in hospital, the baby was found to be MRSA positive. At that point it was decided to look for a possible source, such as other family members and house-hold animals, including pigs on the farm, since those were reported as a possible source of MRSA earlier. Swabs were taken from the throat and nares of family members and co-workers. A veterinarian obtained swabs from the nares, throat and perineum of 10 pigs. Swabs were cultured following a national protocol to detect MRSA that included the use of an enrichment broth. Animal and human strains were characterized by PFGE, spa-typing, MLST analysis, SSCmec, AGR typing, and the detection for PVL, LukM, and TSST toxin genes. Three family members, three co-workers, and 8 of the 10 pigs were MRSA positive. With the exception of the initial case (the mother) all persons were solely colonized, with no signs of clinical infections. After digestion with SmaI, none of the strains showed any bands using PFGE. All isolates belonged to spa type t108 and ST398. CONCLUSION: 1. This report clearly shows clonal spread and transmission between humans and pigs in the Netherlands. 2. MLST sequence type 398 might be of international importance as pig-MRSA, since this type was shown earlier to be present in epidemiologically unrelated French pigs and pig-farmers. 3. Research is needed to evaluate whether this is a local problem or a new source of MRSA, that puts the until now successful Search and Destroy policy of the Netherlands at risk.
Authors: Stephen Murchan; Mary Elizabeth Kaufmann; Ariane Deplano; Raf de Ryck; Marc Struelens; Christina Elsberg Zinn; Vivian Fussing; Saara Salmenlinna; Jaana Vuopio-Varkila; Névine El Solh; Christina Cuny; Wolfgang Witte; Panayotis T Tassios; Nikolas Legakis; Willem van Leeuwen; Alex van Belkum; Anna Vindel; Idoia Laconcha; Javier Garaizar; Saara Haeggman; Barbro Olsson-Liljequist; Ulrika Ransjo; Geoffrey Coombes; Barry Cookson Journal: J Clin Microbiol Date: 2003-04 Impact factor: 5.948
Authors: Edine W Tiemersma; Stef L A M Bronzwaer; Outi Lyytikäinen; John E Degener; Paul Schrijnemakers; Nienke Bruinsma; Jos Monen; Wolfgang Witte; Hajo Grundman Journal: Emerg Infect Dis Date: 2004-09 Impact factor: 6.883
Authors: Joan A Casey; Frank C Curriero; Sara E Cosgrove; Keeve E Nachman; Brian S Schwartz Journal: JAMA Intern Med Date: 2013-11-25 Impact factor: 21.873
Authors: Brigitte A van Cleef; Erwin J M Verkade; Mireille W Wulf; Anton G Buiting; Andreas Voss; Xander W Huijsdens; Wilfrid van Pelt; Mick N Mulders; Jan A Kluytmans Journal: PLoS One Date: 2010-02-25 Impact factor: 3.240
Authors: Ole L Nielsen; Tine Iburg; Bent Aalbaek; Páll S Leifsson; Jørgen S Agerholm; Peter Heegaard; Mette Boye; Sofie Simon; Kristine B Jensen; Sophie Christensen; Karin Melsen; Anne K Bak; Elín R Backman; Mia H Jørgensen; Désirée K Groegler; Asger L Jensen; Mads Kjelgaard-Hansen; Henrik E Jensen Journal: Acta Vet Scand Date: 2009-03-27 Impact factor: 1.695
Authors: Leo M Schouls; Emile C Spalburg; Martijn van Luit; Xander W Huijsdens; Gerlinde N Pluister; Marga G van Santen-Verheuvel; Han G J van der Heide; Hajo Grundmann; Max E O C Heck; Albert J de Neeling Journal: PLoS One Date: 2009-04-03 Impact factor: 3.240
Authors: R Köck; J Harlizius; N Bressan; R Laerberg; L H Wieler; W Witte; R H Deurenberg; A Voss; K Becker; A W Friedrich Journal: Eur J Clin Microbiol Infect Dis Date: 2009-08-25 Impact factor: 3.267
Authors: Hajo Grundmann; David M Aanensen; Cees C van den Wijngaard; Brian G Spratt; Dag Harmsen; Alexander W Friedrich Journal: PLoS Med Date: 2010-01-12 Impact factor: 11.069
Authors: Inge van Loo; Xander Huijsdens; Edine Tiemersma; Albert de Neeling; Nienke van de Sande-Bruinsma; Desiree Beaujean; Andreas Voss; Jan Kluytmans Journal: Emerg Infect Dis Date: 2007-12 Impact factor: 6.883